AstraZeneca returns several compounds to Targacept

(Reuters) – Biotech company Targacept Inc said British drugmaker AstraZeneca would return rights to several pre-clinical compounds, sending the U.S. company’s shares down 10 percent in extended…

    

Leave a Reply

Your email address will not be published.